Venus Remedies Limited Joins AMR Innovation Hub
Venus Remedies takes its fight against AMR to next level, joins India AMR Innovation Hub!
Venus Remedies Limited has joined the India Antimicrobial Resistance (AMR) Innovation Hub (IAIH), a global partnership of government and non-government organizations committed to combating the growing threat of AMR. The partnership aims to accelerate the development of new antibiotics and other treatments for bacterial infections that are resistant to current treatments.
IAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid. Chaired by the Principal Scientific Adviser to the Government of India, the IAIH has many members from the government, academia, industry, and philanthropic, and not-for-profit organizations, like the World Health Organisation (WHO), Bill and Melinda Gates Foundation, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Global Antibiotic Research & Development Partnership (GARDP) and Indian Council of Medical Research (ICMR) which have joined hands to develop suitable public health policies, build capacities, nurture state-of-the-art R&D and undertake AMR stewardship activities to counter the challenge posed by drug-resistant pathogens.
AMR is one of the most pressing public health challenges facing the world today. According to the World Health Organization, AMR could cause up to 10 million deaths globally by 2050 if left unchecked. The AMR Innovation Hub was established to address this issue by bringing together experts from around the world to collaborate on new solutions.
The company has joined the Convergent Global Think Tank to help develop and implement sustainable solutions for reducing India’s burgeoning AMR burden in collaboration with national and international stakeholders across the AMR innovation ecosystem.
As a member of the AMR Innovation Hub, Venus Remedies Limited will work alongside other members to develop and implement new strategies for combating AMR. The company's expertise in the development and manufacturing of high-quality antibiotics and other antimicrobial agents will be a valuable asset in this effort.
Venus Remedies Limited has a long history of innovation in the healthcare industry, with a particular focus on developing new treatments for infectious diseases. The company's commitment to research and development has led to the development of several innovative antimicrobial agents, including the novel antibiotic Potentox.
By joining the AMR Innovation Hub, Venus Remedies Limited has once again demonstrated its commitment to advancing healthcare standards worldwide. The company's participation in this global effort to combat AMR underscores its dedication to improving the lives of patients around the world.
